CVS Health Corporation (FRA:CVS)
58.81
-0.69 (-1.16%)
At close: May 7, 2025, 10:00 PM CET
CVS Health Revenue
CVS Health had revenue of $94.07B USD in the quarter ending March 31, 2025, with 6.92% growth. This brings the company's revenue in the last twelve months to $376.74B, up 4.75% year-over-year. In the year 2024, CVS Health had annual revenue of $370.66B with 3.93% growth.
Revenue (ttm)
$376.74B
Revenue Growth
+4.75%
P/S Ratio
0.22
Revenue / Employee
$1.26M
Employees
300,000
Market Cap
76.12B EUR
Revenue Chart
* This company reports financials in USD.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 370.66B | 14.03B | 3.93% |
Dec 31, 2023 | 356.62B | 34.99B | 10.88% |
Dec 31, 2022 | 321.63B | 30.72B | 10.56% |
Dec 31, 2021 | 290.91B | 23.00B | 8.59% |
Dec 31, 2020 | 267.91B | 12.14B | 4.75% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
SAP SE | 35.15B |
Siemens Aktiengesellschaft | 76.54B |
Deutsche Telekom AG | 118.43B |
Allianz SE | 107.35B |
Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München | 61.15B |
Rheinmetall AG | 9.75B |
Siemens Energy AG | 35.76B |
Deutsche Börse AG | 5.95B |
CVS Health News
- 2 days ago - Kirby McInerney LLP Announces Investigation of Claims Against CVS Health Corporation (CVS) on Behalf of Investors - GlobeNewsWire
- 2 days ago - Build A 12%+ Yield On Cost By 2035 With May's Top 10 High-Yield Picks - Seeking Alpha
- 2 days ago - Activist investor Glenview Capital reduces stake in CVS Health - Reuters
- 2 days ago - Glenview Capital Issues Statement on CVS Health - PRNewsWire
- 5 days ago - Notable healthcare headlines for the week: Gilead, CVS Health, Sanofi in focus - Seeking Alpha
- 5 days ago - CVS Health (CVS) Exceeds Earnings Expectations, Analysts Maintain Revenue Forecasts - GuruFocus
- 5 days ago - CVS Health (CVS) Exceeds Q1 Expectations with Revenue and EPS Gains - GuruFocus
- 7 days ago - Eli Lilly Stock Offers Buying Opportunity For Goldman Sachs. Concerns Over CVS Setback Are Overblown, Analysts Say - Benzinga